Search results
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
CNBC Awaaz· 13 hours agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
Why smoking and vaping can worsen your diabetes
Indian Express· 6 days agoFor a long time through these columns, I have been trying to explain why smoking is the worst enemy of people with diabetes and needs to be given up at...
Diet Coke vs Regular Coke: Which one should you have? | - Times of India
The Times of India· 8 hours agoWhen it comes to soft drinks, the debate between Diet Coke and Regular Coke is a long-standing one....
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro - ET HealthWorld | Pharma
The Economic Times· 13 hours agoHyderabad: An Indian government-approved expert panel has advised the country's drug regulator to...
India plans incentives for diabetes, obesity drug makers in 2026, government official says - ET...
The Economic Times· 4 days agoBengaluru: India is planning to offer incentives to promote local manufacturing of GLP-1 drugs used...
Falsified Ozempic reported from more countries: WHO says, on popular diabetes and weight loss drug
The Hindu· 1 day agoAt least 14 countries have reported the detection of falsified Ozempic, a World Health Organization representative said, as demand for the popular diabetes and weight loss ...
Kids at risk of Paediatric Diabetes: What can parents do? - Times of India
The Times of India· 2 days agoAs a paediatrician on the front lines for over 15 years, I've witnessed the incredible resilience of...
India to manufacture medication for diabetes, obesity under PLI by 2026: Report
Firstpost· 3 days agoIncentives are being planned by India in 2026 to encourage domestic production of GLP-1 medications,...
FDA expands Fractyl endoscopy trial to include untreated diabetes patients
Medical Device Network· 7 days agoThe REVITALIZE-1 (NCT04419779) trial is set to examine the company’s device which is designed to...
Novo Nordisk shares results from trial of semaglutide for type 2 diabetes and CKD
Clinical Trials Arena· 7 days agoDanish pharmaceutical company Novo Nordisk has reported full results from the Phase III FLOW...